Cathay Biotech Inc. (SHA: 688065)
China
· Delayed Price · Currency is CNY 34.28
-0.98 (-2.78%)
Sep 6, 2024, 3:00 PM CST
Cathay Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 2,451 | 2,067 | 2,332 | 2,296 | 1,488 | 1,779 | Upgrade
|
| Other Revenue | 77.11 | 47.17 | 108.67 | 67.67 | 9.49 | 137.3 | Upgrade
|
| Revenue | 2,528 | 2,114 | 2,441 | 2,363 | 1,497 | 1,916 | Upgrade
|
| Revenue Growth (YoY) | 15.82% | -13.39% | 3.28% | 57.86% | -21.87% | 9.05% | Upgrade
|
| Cost of Revenue | 1,814 | 1,535 | 1,612 | 1,526 | 808.77 | 1,065 | Upgrade
|
| Gross Profit | 713.75 | 579.23 | 829.2 | 837.21 | 688.42 | 851.14 | Upgrade
|
| Selling, General & Admin | 224.22 | 221.61 | 232.28 | 175.11 | 143.25 | 214.11 | Upgrade
|
| Research & Development | 203.01 | 189.13 | 187.71 | 133.53 | 84.3 | 90.16 | Upgrade
|
| Other Operating Expenses | 39.64 | 9.21 | -4.09 | 22.94 | 10.45 | 17.61 | Upgrade
|
| Operating Expenses | 469.3 | 413.68 | 422.59 | 337.95 | 241.23 | 320.18 | Upgrade
|
| Operating Income | 244.45 | 165.55 | 406.61 | 499.25 | 447.19 | 530.96 | Upgrade
|
| Interest Expense | -30.98 | -32.17 | -20.01 | -16.29 | -3.86 | -17.03 | Upgrade
|
| Interest & Investment Income | 177.88 | 219.77 | 236.78 | 229.61 | 52.18 | 15.52 | Upgrade
|
| Earnings From Equity Investments | -7.83 | -7.82 | -3.71 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -25.12 | 29.59 | 82.97 | -14.14 | -18.26 | 8.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.14 | -5.7 | -4.61 | -0.59 | -0.32 | 7.86 | Upgrade
|
| EBT Excluding Unusual Items | 355.25 | 369.22 | 698.03 | 697.84 | 476.93 | 545.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 9.15 | 8.05 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.07 | - | - | -2.47 | Upgrade
|
| Asset Writedown | -0.26 | -0.26 | -0.02 | -0.06 | -1.15 | - | Upgrade
|
| Other Unusual Items | 79.97 | 79.97 | -2.09 | 26.66 | 35.85 | 4.96 | Upgrade
|
| Pretax Income | 434.96 | 448.92 | 695.99 | 724.45 | 520.79 | 555.87 | Upgrade
|
| Income Tax Expense | 46.79 | 40.39 | 83.34 | 90.94 | 63.45 | 76.99 | Upgrade
|
| Earnings From Continuing Operations | 388.17 | 408.54 | 612.65 | 633.51 | 457.34 | 478.88 | Upgrade
|
| Minority Interest in Earnings | -16.06 | -42.01 | -59.39 | -38.79 | 0.33 | - | Upgrade
|
| Net Income | 372.11 | 366.52 | 553.27 | 594.72 | 457.67 | 478.88 | Upgrade
|
| Net Income to Common | 372.11 | 366.52 | 553.27 | 594.72 | 457.67 | 478.88 | Upgrade
|
| Net Income Growth | -18.87% | -33.75% | -6.97% | 29.94% | -4.43% | 2.70% | Upgrade
|
| Shares Outstanding (Basic) | 581 | 582 | 582 | 583 | 543 | 508 | Upgrade
|
| Shares Outstanding (Diluted) | 581 | 582 | 582 | 583 | 543 | 508 | Upgrade
|
| Shares Change (YoY) | -1.00% | -0.10% | -0.12% | 7.38% | 6.91% | 1.57% | Upgrade
|
| EPS (Basic) | 0.64 | 0.63 | 0.95 | 1.02 | 0.84 | 0.94 | Upgrade
|
| EPS (Diluted) | 0.64 | 0.63 | 0.95 | 1.02 | 0.84 | 0.94 | Upgrade
|
| EPS Growth | -18.05% | -33.68% | -6.86% | 21.01% | -10.61% | 1.11% | Upgrade
|
| Free Cash Flow | -685.6 | -1,000 | -3,395 | -880.49 | -248.15 | -151.52 | Upgrade
|
| Free Cash Flow Per Share | -1.18 | -1.72 | -5.83 | -1.51 | -0.46 | -0.30 | Upgrade
|
| Dividend Per Share | 0.190 | 0.190 | 0.180 | 0.321 | 0.571 | - | Upgrade
|
| Dividend Growth | 5.56% | 5.56% | -44.00% | -43.75% | - | - | Upgrade
|
| Gross Margin | 28.23% | 27.40% | 33.97% | 35.42% | 45.98% | 44.42% | Upgrade
|
| Operating Margin | 9.67% | 7.83% | 16.66% | 21.12% | 29.87% | 27.71% | Upgrade
|
| Profit Margin | 14.72% | 17.34% | 22.66% | 25.16% | 30.57% | 24.99% | Upgrade
|
| Free Cash Flow Margin | -27.12% | -47.32% | -139.06% | -37.25% | -16.57% | -7.91% | Upgrade
|
| EBITDA | 547.09 | 446.49 | 671.73 | 667.79 | 565.51 | 647.24 | Upgrade
|
| EBITDA Margin | 21.64% | 21.12% | 27.52% | 28.25% | 37.77% | 33.78% | Upgrade
|
| D&A For EBITDA | 302.64 | 280.95 | 265.12 | 168.54 | 118.32 | 116.27 | Upgrade
|
| EBIT | 244.45 | 165.55 | 406.61 | 499.25 | 447.19 | 530.96 | Upgrade
|
| EBIT Margin | 9.67% | 7.83% | 16.66% | 21.12% | 29.87% | 27.71% | Upgrade
|
| Effective Tax Rate | 10.76% | 9.00% | 11.97% | 12.55% | 12.18% | 13.85% | Upgrade
|
| Revenue as Reported | 2,528 | 2,114 | 2,441 | 2,363 | 1,497 | 1,916 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.